Titlebook: Basic and Clinical Research on Renal Cell Carcinoma; Gerd Staehler,Sigmund Pomer Conference proceedings 1992 Springer-Verlag Berlin Heidel

CURL

Cytotoxic Chemotherapy Phase II Trials Between 1983 and 1990 for Advanced Renal Cell Carcinomaenced by less than 5% to 15% of cases achieving significant tumor regression, that is, complete remission (CR) and partial (PR) remission [3, 4, 10]. While chemotherapy has become an integral component of multidisciplinary therapies for most solid tumors, the absence of even modest antitumor activit